SIFI
Manufacturing · Italy · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Via Ercole Patti 36, Aci Sant'Antonio, S...Phone Number
+39 957922111Website
www.sifigroup.comRevenue
$168.8 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About SIFI
SIFI Group is an international ophthalmic healthcare company that develops, manufactures, and markets a wide range of eye care solutions including pharmaceutical treatments, medical devices, surgical products, and diagnostic technologies for ocular diseases, operating as an integrated life sciences organization that spans research, development, production, and commercialization, with a strong focus on improving patient vision and quality of life through innovation in ophthalmology and maintaining a global presence across multiple regions through subsidiaries, partnerships, and distribution networks while serving healthcare professionals with advanced therapeutic and surgical solutions for eye health.Explore more
SIFI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SIFI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on SIFI recently announced quarterly report
SIFI, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at SIFI
Click to see if SIFI had a recent Job posting/layoffs
Check if SIFI has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when SIFI launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once SIFI has new funding data
Check out if SIFI is spiking on competitors!
Recommended Actions
Find VP level buyers at SIFI
Find more new buyers
Company Profile Activity
Activity Insights
SIFI is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SIFI is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SIFI.
SIFI Tech Stack
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Person-Based
Project
Business Finance, Finance, Financial Operations
SIFI News & Media
SIFI merges into Faes Farma to become its ophthalmic franchise and expand international access to its portfolio and pipeline
The transaction will enable strong commercial synergies, thanks to Faes Farma's presence in complementary markets and recent acquisition of Laboratorios Edol It enables funding further development of SIFI's portfolio, most notably Akantior in the USA SIFI's existing infrastructure,...SIFI receives Marketing Authorisation and Promising Innovative Medicine Designation for AKANTIOR® in the UK
MHRA granted on 6th May the Promising Innovative Medicine (PIM) Designation MHRA granted on 15th May the Marketing Authorisation, confirming the Orphan Drug Designation and the New Active Substance status CATANIA, Italy, May 19, 2025 /PRNewswire/ -- SIFI, a leading international...SIFI PRESENTED NEW DATA ON XANTERDES AT ARVO 2023
CATANIA, Italy, May 2, 2023 /PRNewswire/ -- SIFI, a leading pharmaceutical company in the development of innovative solutions for the treatment of eye diseases, presented a series of scientific posters regarding preclinical and clinical research on its innovative product pipeline, during...AffaMed Technologies Announces TFDA Approval of MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready IOLs for Cataract Treatment in Taiwan
SHANGHAI, March 20, 2023 /PRNewswire/ -- AffaMed Technologies, a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced that the Taiwan Food and Drug Administration ("TFDA") has approved its MINI WELL, MINI WELL PROXA, MINI WELL TORIC and MINI 4 Ready intraocular lens ("IOL") surgical implants for use in cataract treatment in Taiwan. MINI WELL, MINI WELL PROXA and MINI WELL TORIC are presbyopia-correcting IOLs that can provide progressive extended depth-of-focus
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SIFI
Sign Up For FreeTo access detailed company insights
SIFI Group is an international ophthalmic healthcare company that develops, manufactures, and markets a wide range of eye care solutions including pharmaceutical treatments, medical devices, surgical products, and diagnostic technologies for ocular diseases, operating as an integrated life sciences organization that spans research, development, pro... Read More
